Anges MG’s high-blood pressure DNA vaccine creates an antibody to angiotensin II”, a protein involved in blood pressure increase. Whereas present medications must be taken every day, the injection DNA vaccine is administered only once and acts over a long period of time. Anges MG is preparing for Phase I II clinical trials in Australia.”

Anges MG news release, July 19, 2017